These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5747401)

  • 1. [Jaundice in diabetics treated with sulfonylureas. On a clinical case of jaundice caused by tolazamide].
    Rotolo V
    Friuli Med; 1968; 23(2):257-75. PubMed ID: 5747401
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolazamide in the treatment of diabetes mellitus.
    Baird IM; Evans JH; Hirst J; Longson D
    Practitioner; 1967 Feb; 198(184):264-7. PubMed ID: 6038982
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of oral hypoglycemic agents. VI. Comparative study on acute oral overload using tolbutamide and tolazamide in normal and diabetic subjects. Various aspects of the prolonged use of tolazamide in comparison with other sulfonylureas].
    Pereira VG; Wajchenberg BL; Shnaider J
    Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):133-42. PubMed ID: 5322747
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with sulfonylurea tolazamide in an out-patient clinic for diabetics].
    Kanzler G; Trenkner G; Rausch-Stroomann JB
    Arzneimittelforschung; 1968 Oct; 18(10):1345-8. PubMed ID: 5756166
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of tolazamide in the treatment of diabetes mellitus.
    Beidleman B; Prevatt AL; Palmer RC
    J Fla Med Assoc; 1966 Mar; 53(3):191-3. PubMed ID: 5323398
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the metabolism of ketone bodies and pyruvic acid in patients with various endocrine disorders. 3. Effects of sulfonylureas, biguanides and insulin on the concentration of blood ketone bodies and pyruvate in diabetics].
    Morikami S
    Naika Hokan; 1966 Oct; 13(10):445-53. PubMed ID: 6009579
    [No Abstract]   [Full Text] [Related]  

  • 7. [Statistical study of 1,120 diabetics treated with an oral antidiabetic].
    Lyon Med; 1969 Mar; 221(9):465-79. PubMed ID: 5360535
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of tolinase (tolazamide) in diabetes mellitus].
    Genes SG; Grinchenko TS; Lobanovskaia LI
    Vrach Delo; 1969 Apr; 4():40-4. PubMed ID: 5373588
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with glibenclamide in 300 diabetics.
    Beyer J; Schöffling K
    Postgrad Med J; 1970 Dec; ():Suppl:78-83. PubMed ID: 5500516
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypoglycemic complications caused by sulfanylurea].
    Halmos T; Korányi L
    Orv Hetil; 1969 May; 110(21):1193-9. PubMed ID: 5793522
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe hypoglycaemic reactions in Ethiopian diabetics.
    Lester FT
    Ethiop Med J; 1982 Jan; 20(1):33-7. PubMed ID: 7032908
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic cholestasis following prolonged tolbutamide administration.
    Gregory DH; Zaki GF; Sarcosi GA; Carey JB
    Arch Pathol; 1967 Aug; 84(2):194-201. PubMed ID: 21936121
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
    Ravipati G; Aronow WS; Ahn C; Sujata K; Saulle LN; Channamsetty V; Weiss MB
    Am J Ther; 2006; 13(5):400-3. PubMed ID: 16988534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of oral hypoglycemic agents in the therapeutic approach to diabetic obesity].
    Albert J; Ekoé JM
    Sem Hop; 1983 Sep; 59(29-30):2135-40. PubMed ID: 6312587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tolazamide in the control of diabetes mellitus].
    Ramos JV
    Prensa Med Mex; 1969; 34(1):66-7. PubMed ID: 5787505
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes mellitus in the elderly.
    Singh I; Marshall MC
    Endocrinol Metab Clin North Am; 1995 Jun; 24(2):255-72. PubMed ID: 7656891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolanase - a sulphonylurea antidiabetic agent.
    Drug Ther Bull; 1968 Mar; 6(7):27-8. PubMed ID: 5655488
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.
    Shorr RI; Ray WA; Daugherty JR; Griffin MR
    Arch Intern Med; 1997 Aug 11-25; 157(15):1681-6. PubMed ID: 9250229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolinase--a new oral antidiabetic drug.
    Med Lett Drugs Ther; 1966 Sep; 8(19):77-8. PubMed ID: 5971398
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypoglycemic states during sulfonylurea therapy].
    Gurtner B; Bäbler M; Wegmann T
    Ther Umsch; 1969 May; 26(5):283-7. PubMed ID: 5801613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.